CNS Pharmaceuticals, Inc.

CNSP
$5.07 (+ $0.00 + 0.00%)
Last updated: 2026-07-29 06:51 UTC
CNSP Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS18978H1023
CUSIP18978H102
Market Price5.07
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.01
EPS776.03
Market Cap$3.8M
Book Value17.25
Price to Book0.354
Beta0.45
52w High114.0
52w Low4.93
Next Earnings DateN/A

CNS Pharmaceuticals, Inc. trades under ticker CNSP on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US18978H1023, CUSIP 18978H102. Also searched as CNS Pharmaceuticals.

Related researchCNSP stock priceCNSP share priceCNS Pharmaceuticals stockCNS Pharmaceuticals share price18978H102
About the Company
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Price History